Study title:
A double-blind, single-dose analgesic study comparing the safety and effectiveness of ibuprofen lysine 200 mg, acetylsalicylic acid 500 mg and placebo for the treatment of outpatients experiencing moderate to severe postoperative dental pain / A double-blind, single-dose study to investigate plasma ibuprofen concentrations and their relationship to clinicalanalgesic response in patients treated with dexibuprofen lysine, ibuprofen lysinate, ibuprofen (Motrin) or placebo for the relief of moderate or severe postoperative dental pain / a double-blind single-dose, analgesic pilot study comparing the safety and effectiveness of dexiprofen lysine ((s)-ibuprofen lysinate) 400 mg, (R)-Ibuprofen Lysinate 400mg, and placebo for the treatment of outpatients experiencing moderate or severe postope...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: IBUPROFEN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|